Akero Therapeutics (AKRO)
(Delayed Data from NSDQ)
$26.41 USD
+0.06 (0.23%)
Updated Sep 6, 2024 04:00 PM ET
After-Market: $26.41 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/11/2024
Time: -- |
9/2024 | $-0.90 | 0.00% |
Earnings Summary
For their last quarter, Akero Therapeutics (AKRO) reported earnings of -$0.81 per share, beating the Zacks Consensus Estimate of $-0.90 per share. This reflects a positive earnings surprise of 10.00%. Look out for AKRO's next earnings release expected on November 11, 2024. For the next earning release, we expect the company to report earnings of -$0.90 per share, reflecting a year-over-year decrease of 26.76%.
Earnings History
Price & Consensus
Zacks News for AKRO
Xenon (XENE) Q2 Earnings Miss, Pipeline in Focus, Stock Down
AKRO: What are Zacks experts saying now?
Zacks Private Portfolio Services